Summit report progress in DMD programme at International conferenceReleased: 29th April 2008
Positive results from Phase I clinical trial of SMT D002 for the treatment of acneReleased: 15th April 2008
Summit Presents the Benefits Zebrafish Bring to Drug Discovery at International ConferencesReleased: 9th April 2008
£500,000 Contract Wins by Dextra Carbohydrate Service BusinessReleased: 21st February 2008
Pre-close Trading StatementReleased: 31st January 2008
SMT D002 Enters Phase II Clinical Trials for the treatment of sialorrhoea, a symptom of Parkinson's diseaseReleased: 16th January 2008
